A 62-year-old woman with longstanding diabetes and hypertension presents with creatinine 150 µmol/L (baseline 95), eGFR 38 mL/min/1.73 m², and albumin:creatinine ratio 45 mg/mmol. According to Canadian CKD guidelines, which pharmacologic intervention is recommended to slow progression?